AI Diagnostic Tool Helps Doctors Visualize Post-COVID Lung Damage
New tool reveals hidden features on chest scan images. A new computer-aided diagnostic tool developed by King Abdullah University of Science & Technology (KAUST) scientists…
New tool reveals hidden features on chest scan images. A new computer-aided diagnostic tool developed by King Abdullah University of Science & Technology (KAUST) scientists…
UC San Diego researchers describe an imbalance of opposing cell signals that cause deadly disease, and how a novel monoclonal antibody therapy might treat or…
Findings shine light on underpinnings of COPD, pave new direction for future research on treatments. A new type of cell that resides deep within human…
Experimental drug reduces airway mucus that exacerbates common lung diseases. A multicenter research team co-led by The University of Texas MD Anderson Cancer Center developed the…
Disease of the small airways in the lungs is a potential long-lasting effect of COVID-19, according to a new study published in the journal Radiology….
University of Melbourne-led research has shown the flavonoid pinocembrin, derived from Australian eucalyptus trees, has strong anti-inflammatory properties and could be safe and effective at…
Researchers at the University of Toronto have identified hundreds of new proteins that could play a role in cystic fibrosis, and which may shed light…
An FDA-approved drug that has been in clinical use for more than 70 years may protect against lung injury and the risk of blood clots…
A team of scientists led by Cold Spring Harbor Laboratory (CSHL) have discovered that disulfiram, an FDA-approved drug, prevents the immune system from producing toxic…
New research has led to a breakthrough in understanding an important driver of recurrent chest infections in children. Many children experience a prolonged wet cough…
A widely available and affordable drug, heparin, limits lung damage when inhaled by COVID-19 patients, according to world-first findings by researchers from The Australian National…
A combined treatment strategy targeting SARS-CoV-2 symptoms and severe lung tissue injury is essential to minimize lung sequelae—chronic complications resulting from COVID-19 infection, according to…
From our first breath, our lungs are exposed to microorganisms, such as bacteria and viruses. Thanks to immune cells in the lungs, so-called macrophages, we…
When it comes to studying lungs, humans take up all the air, but it turns out scientists have a lot to learn from lizards. A…
61-year-old patient suffered from severe post-COVID-19 respiratory failure after three months on an artificial lung that oxygenates blood and multiple treatment-related complications. Doctors in Lisbon…
SARS-CoV-2 prevents lung tissue repair, regeneration. Lung autopsy and plasma samples from people who died of COVID-19 have provided a clearer picture of how the…
Findings have implications in understanding, preventing and treating multiple lung diseases. Lung immunity is essential to combat all pulmonary diseases, including COVID-19, pneumonia, lung cancer,…
Malignant tumors can enhance their ability to survive and spread by suppressing antitumor immune cells in their vicinity, but a study led by researchers at…